Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Radicava
Pharma
Mitsubishi Tanabe models economic impact of IV-to-oral switch
The researchers describe a review of existing evaluations of the impact of oral formulations and their own model for quantifying the effect.
Nick Paul Taylor
Aug 2, 2022 7:40am
Hengrui, Merck-Kelun, Dr. Reddy's and more—Fierce Pharma Asia
May 20, 2022 9:15am
Oral version of Mitsubishi's ALS drug Radicava gets FDA blessing
May 13, 2022 9:31am
Radicava stalls in EU as skeptical regulators demand new ALS trial
May 31, 2019 12:19pm
New Mitsubishi Tanabe tool finds ALS care centers for patients
May 22, 2019 9:22am
Samsung BioLogics, Gardasil and more—FiercePharmaAsia
Nov 16, 2018 10:12am
